Guifang Guo
8PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Oct 08, 2025
Efficacy and Safety of Different Sequences for mFOLFIRINOX (or SOXIRI) and Gemcitabine Plus Albumin-Bound Paclitaxel in Unresectable Pancreatic Cancer.Silan Huang, Lingli Huang, Dongsheng Zhang
|Dec 17, 2024
Predictive significance of MPT-driven necrosis-related genes signature in gastric cancer and their impact on the tumor microenvironment.Silan Huang, Lingli Huang, Qi Jiang
|Jul 12, 2023
Efficacy and safety of SOXIRI versus mFOLFIRINOX in advanced pancreatic cancer.Xujia Li, Jinsheng Huang, Fenghua Wang
|May 15, 2023
Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two-sample Mendelian randomization analysis of European and East Asian populations.Jinsheng Huang, Xujia Li, Jicheng Hong
|Mar 03, 2023
Analysis of Risk Factors for Distant Metastasis of Pancreatic Ductal Adenocarcinoma without Regional Lymph Node Metastasis and a Nomogram Prediction Model for Survival.Jinsheng Huang, Xujia Li, Qi Jiang
|Dec 28, 2022
Comparison the efficacy and safety of different neoadjuvant regimens for resectable and borderline resectable pancreatic cancer: a systematic review and network meta-analysis.Xujia Li, Jinsheng Huang, Chang Jiang
Pageof 2
